Page last updated: 2024-12-07

o(6)-methyldeoxyguanosine triphosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

o(6)-Methyldeoxyguanosine triphosphate (o(6)-Me-dGTP) is a modified nucleotide that plays a crucial role in DNA replication and repair. It is formed when the guanine base in deoxyguanosine triphosphate (dGTP) is methylated at the O6 position. This modification is often introduced by alkylating agents, such as those found in tobacco smoke and certain industrial chemicals. o(6)-Me-dGTP is important for research because it can lead to mutations in DNA, as it mispairs with thymine during DNA replication, resulting in transitions from G:C to A:T base pairs. This can contribute to the development of cancer. o(6)-Me-dGTP is also a substrate for DNA repair enzymes, such as O(6)-methylguanine-DNA methyltransferase (MGMT). MGMT removes the methyl group from o(6)-Me-dGTP, preventing mutations. Understanding the role of o(6)-Me-dGTP in DNA replication, repair, and mutagenesis is crucial for developing new therapeutic strategies for cancer prevention and treatment.'

Cross-References

ID SourceID
PubMed CID115311
SCHEMBL ID205857
MeSH IDM0081493

Synonyms (11)

Synonym
2'-deoxy-6-o-methoxyguanosine 5'-(tetrahydrogen triphosphate)
o(6)-methyldeoxyguanosine triphosphate
guanosine 5'-(tetrahydrogen triphosphate), 2'-deoxy-6-o-methoxy-
o6-methyldeoxyguanosine triphosphate
9h-purin-2-amine, 9-(2-deoxy-5-o-(hydroxy((hydroxy(phosphonooxy)phosphinyl)oxy)phosphinyl)-beta-d-erythro-pentofuranosyl)-6-methoxy-
ccris 3387
63642-16-0
[[(2r,3s,5r)-5-(2-amino-6-methoxypurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate
SCHEMBL205857
9-[2-deoxy-5-o-(hydroxy{[hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl)pentofuranosyl]-6-methoxy-3,9-dihydro-2h-purin-2-imine
DTXSID00979868
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (83.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.35 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]